Product/Composition:- | Baricitinib |
---|---|
Strength:- | 2 mg, 4 mg |
Form:- | Tablet |
Reference Brands:- | Olumiant®(EU & US- Emergency Use Authorization (EUA) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Baricitinib (Olumiant®) is a JAK inhibitor used for rheumatoid arthritis and COVID-19 treatment in hospitalized adults, approved in the US and EU. Available in 1 mg, 2 mg, and 4 mg tablets, it’s sourced globally via PharmaB2B platforms. Connect with GMP-certified manufacturers offering Baricitinib for bulk supply, tenders, and institutional procurement, with full regulatory documentation and global export support.
Baricitinib, marketed as Olumiant® by Eli Lilly, is a JAK inhibitor approved in the US and EU for rheumatoid arthritis and authorized for COVID-19 treatment in hospitalized adults. Available in 1 mg, 2 mg, and 4 mg oral tablets, it helps reduce inflammation and cytokine storms in severe COVID-19 cases. Through leading PharmaB2B platforms, global buyers can source Olumiant or Baricitinib generics from GMP-certified manufacturers in India, China, and Bangladesh. Ideal for hospital tenders and bulk procurement, Baricitinib is widely distributed with full regulatory support, competitive pricing, and fast international shipping.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications